Up next on the GSK calendar
ESG Investor Education Event (Clinical Trial Diversity)Speeches and presentations
During the 45 minute session Alberto Fernandez, SVP of Global Clinical Operations at GSK and Dr. Kimberly Smith, SVP and Head of R&D at ViiV Healthcare, will provide insights on the importance of clinical trial diversity including support from a 17-year retrospective study. During the session, the leaders will also provide an overview of GSK’s work to ensure clinical trials reflect the populations most impacted by a disease and explore a HIV case study that demonstrates the power of clinical trial diversity in action. The presentation will be followed by an opportunity for audience Q&A. The presentation will be recorded and available on the Speeches and presentations page after the event.
ESG Investor Education Event (Clinical Trial Diversity)
We will announce our second quarter 2023 results on Wednesday 26 July.
We will announce our third quarter 2023 results on Wednesday 01 November.
Past event materials
Search through our archives of speeches and presentations and past quarterly results announcements, both dating back to 2010, as well as the archive of the Annual and Corporate Responsibility reports dating back to 2000.